{"name":"MapLight Therapeutics","slug":"maplight-therapeutics","ticker":"","exchange":"","domain":"maplight.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":138349000,"netIncome":-161152000,"cash":479512000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNeWJGX3A2ZThjSlJDTTRCSzRRaUVrTlk4YnJSTHNwT1JXOE5KQm93cnlhaG1iMl9FVlNBeUVjZTZlbWJldDBReG5vRTVmV0FMMk94TUtpZTZEaUJiQkxBQUpLSWItQWhvQ2lCZGwxSjJqZmg1bkFoT2dhelNxR1ZVSGxCWU9HS2s3UndFUk9ZTQ?oc=5","date":"2025-12-17","type":"pipeline","source":"BioSpace","summary":"6 Biotechs That Could Be Big Pharma’s Next M&A Target - BioSpace","headline":"6 Biotechs That Could Be Big Pharma’s Next M&A Target","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQVUFUTk5STjNhcVRyeUZvRHQ4ejNMdW01eml4cnQ5Zl9aUnlzX1VyTXZKeFVmVUZqbU1rVk1TUmpUUXdraXlkOUlVTWJIaGViTU41WVUyS3dSUElOajVoaGhQaXBKS3dnSnc5TlNVLV9CaUFvWVJLd1B3YThpT1Z4TUx5eDA0VW1DTXdHUFRfUDNjLXlW?oc=5","date":"2025-10-28","type":"pipeline","source":"The Pharma Letter","summary":"MapLight Therapeutics announces pricing of IPO - The Pharma Letter","headline":"MapLight Therapeutics announces pricing of IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFA4ZzRYRHBmb1BtNEd3VjA2eDhsZnFlb2N3QlZOMGdMTTBxYVF2ZEs1OUxzTno0cWZ2cUR0WkZmSWVIVmNVVXNwQzA2SWFtT3FmZG9Na2RxSERFTDJ1MFd6cmZYMnlBQk9KejBEaGQ4N3BlR0VQ?oc=5","date":"2025-10-28","type":"pipeline","source":"pharmaphorum","summary":"MapLight shares track up after $251m IPO - pharmaphorum","headline":"MapLight shares track up after $251m IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9ETG4xQUFtb2dYeW1VLWUwckZtd0JFd1hJNHZ0QUtudDd0TU9CVC1nUHdsb0JkRXFMdVVwc19OeENJTFNrOWZqVnVHSF8xR3k4bGVz?oc=5","date":"2025-10-27","type":"pipeline","source":"FirstWord Pharma","summary":"MapLight raises $250M, second neuro biotech to overcome IPO slump - FirstWord Pharma","headline":"MapLight raises $250M, second neuro biotech to overcome IPO slump","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOc2xLQWtMTWkyMFAxVjBjdGc1OTJkX3RBMjBJdklHWmtlcHlCODN3ZHRIemFsRXdWdFVTYV9sOGstdUZnbWdQTFMydE1mZXBvdDJhVFBsclJTVGZVWDZOem1GZHBZdm1oWk5QM2p3THBwM25ST2pUeV9pQVEyMFFXMkl2OFNJRUdONU1FcWNJNnRLQW05RE9NcmNVa2kwRVd4aU85OWNPZm9CdC12VE9xVDRoQ2xjX3BNWVplZVFkS1FDcWJ3VUJaU1NSOUhma2JzX1ZqbGxPZWRnblpZa255aXFB0gHnAUFVX3lxTE03M0FDa243bGhPZ09tME4zSk5SbkpmaFRsMjBKOWZFOThuUllQNk0tS1FOZTFKaDdzZC1WbjZFYjIzTWxQdHg0RFdfQVVnU1RMMzFnX3JjVTlHUzlITFJPaGZKV3NfOFR2Snp3OVN3MlBfQTVhaHpUS3kzdUprY001RWdGdW1jb281ZnFXbzdvcGNTcU01UUlXaDlESUFiMGg1TjJDT0MtV2o4OHpVUXZDbUpKYXJOM2JWOG1iUFlPYVU1bTNwckNma21GeVlDUU5Cd1dYZTFaUmdOYVB3TjRySmxUb1B5UQ?oc=5","date":"2025-10-27","type":"pipeline","source":"ET Pharma","summary":"Drug developer MapLight Therapeutics valued at $704.3 million after US IPO - ET Pharma","headline":"Drug developer MapLight Therapeutics valued at $704.3 million after US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQZk9Yc244aTVQdERmVnVrNnFlX3h5REdwdW5TR3BKMFpoYUdyOUQ2VWpkVG5uUXZRUDNGeUpJb1hES1A4Sm44STVtLWJyQXhYWjl2b3lCSVJsWXhoRVdnZDh2Vm9XUi1xQ2pIVmc5RzdnU3MzWVZzUUJwczJ5VlZEOE55WWh2U2hKNEpMUm5lbmhCaG9xbmc?oc=5","date":"2025-10-27","type":"pipeline","source":"Fierce Biotech","summary":"MapLight goes public via $250M IPO to fund Cobenfy competitor - Fierce Biotech","headline":"MapLight goes public via $250M IPO to fund Cobenfy competitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNbzRiQW9HbmFyeHhBdnJvMDZXellPOWdDYjNQbmMwY3JHRFZoSklSWVZ0N056anNnTnBLY0NwTk1qbHpLQndjV29rX1ViRUt0bXJLR1BUTlIxSXROTFpZeGcwR2xuR1RYRTQyY21IMEljb2J5TDlUOFBPaG9NOUN1TkMzaHVqNXRDWWozTnYyMHV2RzZ0eWsweGozS2hSajE5aHVvNE1MTmpKbkN6?oc=5","date":"2025-10-08","type":"pipeline","source":"Pharmaceutical Technology","summary":"MapLight’s $251m IPO sees schizophrenia drug developers on top - Pharmaceutical Technology","headline":"MapLight’s $251m IPO sees schizophrenia drug developers on top","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQeWhSZGJYN3A1dlZhLWtpMlBxNmI2dWwybWNOR3BweVkzSFFZMzlIcWNnamo4SlFfQUpGN25OXzhaSWF5U3FaVDRqQklSaFZRLWF4U3ptS1dDTGRfU3c3eTlhcHgxZ3BmbWI1dkYtZ1FtQnA5bGtPVXpzOU1pQ0J5c2lOZ0VvOVZNX2N2dEdWTVBTQlhETlgxcUZxcy16THltMnREVXVHQldrdGRMVnRmTGg1aDJ5QzdvYzdYTHdDdEVlM1Z0QlE?oc=5","date":"2025-10-06","type":"pipeline","source":"PR Newswire","summary":"MapLight Therapeutics Announces Commencement of Initial Public Offering - PR Newswire","headline":"MapLight Therapeutics Announces Commencement of Initial Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOUTFkVjdFNTc3MGRoMk9pdnByS0FlU1FLSHBxMzJLcUpXdHJKdEtweUE3MndYeDZnZDNvRzFXX2ZTUGlIaUdRYWdaaWxoVHJZQmZ6YWtHTG9oZkNGTWRDU09NQnctUzcyb3pYM0tOMUVzSGpicHhWLTdEcXBrN1BCLWxFekNrWnUtdXlEdTVMY05WNm5ramRmdEM5Tm15YVRHYzdxYU9rdjdTUkxDUUU2WnhwWE02Qmp4QUtBNWtFcUc2NVk?oc=5","date":"2025-10-06","type":"pipeline","source":"Reuters","summary":"Drug developer MapLight eyes $704.3 million valuation in US IPO - Reuters","headline":"Drug developer MapLight eyes $704.3 million valuation in US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSDhQd2duSll3VkhpY3Y4aTR2QW1aWWZDdi02aVZMVVJGY1ZnR0R3TzBvQUlxTW1pVG5jTjlIbThoVW9SNXVvbEhhbGNyV1JKdUxZcnIwOV9XQ3hfVHpmTVZWX0ZlbktPMk8yeHVSemNYbU5SblYzN2Z6OGFuMzNYQmlBZmhPN0U2cV9IWmllVWhLOHNzd0k2bnlDSTBpY210SGtvbTFZZ0FpWXlud19SMVppdktrY1hz?oc=5","date":"2025-09-22","type":"pipeline","source":"Fierce Biotech","summary":"Big Pharma-backed MapLight plots IPO to advance neuro pipeline - Fierce Biotech","headline":"Big Pharma-backed MapLight plots IPO to advance neuro pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOWWlzUkZta2d0Y05lZmZ5QTl4YXhqN1I3Z1UxN2VFSnpWbHdyVXVyLTVnMHpTNzFDc0s1TVFqbTF4cnJvR1Y3TjQ3Y2QzeC1wN0luMzd0Z0hwOHV4X1VsRndXRkRZTkZkV3g4ODE1XzA1TEZZck9kVHpJZnZuR3NOXzRVWmlMWnBULXJ5MWVaY29Edndja1ROb0h3?oc=5","date":"2025-09-22","type":"pipeline","source":"BioPharma Dive","summary":"MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug - BioPharma Dive","headline":"MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPUTMxRUt5cC1Ua1ZranNHUTQ4YndEQW1tajR0WnZTQld2cU5pcWFtSkNGYU1OX25kd1Z1aFp6eTRlTDl3R3FQOVZndmRtSllUblA0NGFYTUtVQ2FJX0ZSbldDWEh5X0JzS2lwTDBBZDloRE10SlhjSEFRTTE0aXlWSFdWWVlac1VDWlR5LTJMX1VjNUU2T0lBQ09FcUQ2bW41aDEtN05DZk1BRWxKQWtZeWxudy1JQlFFNE51ag?oc=5","date":"2025-07-28","type":"pipeline","source":"PR Newswire","summary":"MapLight Therapeutics Announces $372.5 Million Series D Financing - PR Newswire","headline":"MapLight Therapeutics Announces $372.5 Million Series D Financing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":138349000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-161152000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":479512000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}